Halogenated psilocybin derivatives and methods of using
US12138276B2 · kind B2 · utility
0Cited by
1References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2024 |
| Grant date | Nov 12, 2024 |
| Priority date | — |
| Expiry date | May 6, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/43
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.